Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FYP99
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,868
Award facts
- Contract value 100% obligated
- $25,868.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on September 3, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, provides 120 capsules of Xtandi 40 mg, an oncology medication used in prostate cancer treatment. The delivery order, valued at $25,868.10 on a firm fixed-price basis, is funded by the Defense Logistics Agency (DLA) and requires completion by September 4, 2025. No set-aside designation was applied to this award, allowing DMS Pharmaceutical Group to compete on an unrestricted basis.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent contract enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply requirements across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of delivery orders for prescription medications and specialty pharmaceutical products serving military health systems.
Quick answers
Who was awarded contract SPE2DB25FYP99?
SPE2DB25FYP99 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FYP99 worth?
The government has obligated $25,868 on SPE2DB25FYP99.
Is contract SPE2DB25FYP99 an order under another contract?
Yes. SPE2DB25FYP99 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP99 competed?
The extent of competition for SPE2DB25FYP99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award